| Title |
Author |
Type |
Date |
Words |
| Breast metastasis from medullary carcinoma of thyroid: A case report with literature view. |
|
Clinical report |
Nov 18, 2020 |
1256 |
| Mickey Mouse Sign on Bone Scan in the Monostotic Form of Paget's Disease Mimicking Osseous Metastasis/Metastazi Taklit Eden Monostotik Tip Paget Hastaligi'nda Mickey Mouse Isareti. |
Kesim, Selin; Turoglu, Halil Turgut; Ozguven, Salih; Ones, Tunc; Erdil, Tanju Yusuf |
Report |
Oct 1, 2020 |
366 |
| The efficacy of positron emission tomography-CT in simultaneously detected nodules in patients with lung cancer. |
Dogan, Coskun; Kiral, Nesrin; Parmaksiz, Elif Torun; Zengin, Omer; Caglayan, Benan; Fidan, Ali; Come |
|
Apr 3, 2020 |
5223 |
| Evaluation of radiotherapy combined with targeted therapy and concurrent radiotherapy, chemotherapy in the treatment of Non-Small Cell Lung Cancer with brain metastasis. |
Yanfeng Sun, Xiaohui Guo, Lingling Zhang, Wenqian Zhang and Yuqin Zuo |
|
Apr 2, 2020 |
3308 |
| Medlab Clinical shares surge on "primary evidence" of NanaBis[TM] cancer trial success. |
|
|
Mar 10, 2020 |
718 |
| ANGLE device plays key role in assessing spread of lung cancer to the brain. |
|
|
Mar 4, 2020 |
434 |
| CytoDyn sees +remarkable outcomes' in metastatic triple-negative breast cancer trial for leronlimab. |
|
|
Mar 3, 2020 |
879 |
| Updated CheckMate -025 Results Show 26% of Patients Treated with Opdivo are Alive at Five Years in Patients with Previously Treated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 19, 2020 |
407 |
| Opdivo Plus Yervoy Demonstrates Continued Survival Benefit at 42-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 19, 2020 |
647 |
| CytoDyn sees positive data for leronlimab in Phase 1b/2 mTNBC and expanded access studies for MBC. |
|
|
Feb 15, 2020 |
913 |
| US Merck's Keytruda in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival as First-Line Treatment for Metastatic Triple-Negative Breast Cancer. |
|
|
Feb 14, 2020 |
1258 |
| Nubeqa Plus Androgen Deprivation Therapy Achieved the Secondary Endpoint of Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer. |
|
|
Feb 4, 2020 |
361 |
| European Commission Approves Janssen for Expanded Use of Erleada for Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Jan 30, 2020 |
217 |
| Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint. |
|
|
Jan 27, 2020 |
1636 |
| A Canadian consensus forum on the management of patients with advanced prostate cancer. |
Saad, Fred; Canil, Christina; Finelli, Antonio; Hotte, Sebastien J.; Malone, Shawn; Shayegan, Bobby; |
|
Jan 25, 2020 |
7582 |
| CytoDyn's impressive run continues for leronlimab in metastatic triple-negative breast cancer and metastatic breast cancer. |
|
|
Jan 23, 2020 |
689 |
| Lynparza regulatory submission granted Priority Review in the US for HRR-mutated metastatic castration-resistant prostate cancer. |
|
|
Jan 20, 2020 |
237 |
| CytoDyn files for breakthrough therapy status for leronlimab in metastatic triple-negative breast cancer. |
|
|
Jan 14, 2020 |
758 |
| Intractable small-bowel obstruction due to urothelial cell carcinoma metastasis to the distal ileum: A rare cause of malignant bowel obstruction. |
Tseng, Yu-Chen; Lin, Hsuan-Hwai; Huang, Shing-Hwa; Wen, Liang-Wei |
|
Jan 1, 2020 |
1521 |
| The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers. |
Dong, Jun; Wu, Liyan; Wang, Fang; Huang, Jinsheng; Hu, Pili; Zhang, Bei; Xia, Liang-ping |
Clinical report |
Dec 31, 2019 |
8239 |
| The Antioxidant Alpha-Lipoic Acid Inhibits Proliferation and Invasion of Human Gastric Cancer Cells via Suppression of STAT3-Mediated MUC4 Gene Expression. |
Yang, Yu; Fang, Erhu; Luo, Jiajun; Wu, Hongxue; Jiang, Yue; Liu, Ying; Tong, Shilun; Wang, Zhihua; Z |
|
Dec 31, 2019 |
5835 |
| Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression. |
Yosra, Macherki; Sameh, Souissi; Randa, Ghedira; Yassmine, Remadi; Sallouha, Gabbouj; Nadia, Bouzid; |
|
Dec 31, 2019 |
7564 |
| Skeletal Muscle Metastasis to Vastus Lateralis from a Urothelial Carcinoma: A Case Report and Review of Its Diagnosis and Management. |
Mainwaring, A.M.; Wells, H.; Banks, T.; Ellul, T.; Bose, P. |
|
Dec 31, 2019 |
2832 |
| Increased Tissue Penetration of Doxorubicin in Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) after High-Intensity Ultrasound (HIUS). |
Khosrawipour, Veria; Reinhard, Soren; Martino, Alice; Khosrawipour, Tanja; Arafkas, Mohamed; Mikolaj |
|
Dec 31, 2019 |
3813 |
| Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer. |
|
|
Dec 30, 2019 |
2269 |
| Seattle submits NDA with FDA for tucatinib to treat metastatic HER2-positive breast cancer. |
|
|
Dec 24, 2019 |
272 |
| Seattle submits NDA with FDA for tucatinib to treat metastatic HER2-positive breast cancer. |
|
|
Dec 24, 2019 |
268 |
| CytoDyn's leronlimab sees strong positive clinical responses in two patients with metastatic breast cancer and mTNBC. |
|
|
Dec 24, 2019 |
634 |
| Continuing Full Induction Regimen Not Beneficial in Metastatic CRC; Maintenance therapy shows benefit versus observation in terms of PFS but not overall survival. |
|
|
Dec 20, 2019 |
268 |
| Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer; ODAC voted that Lynparza demonstrated a clinically meaningful and favourable risk-benefit profile for patients based ... |
|
|
Dec 18, 2019 |
2484 |
| CytoDyn sees positive results as first triple-negative breast cancer patient treated with leronlimab. |
|
|
Dec 4, 2019 |
441 |
| NantKwest Releases Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers. |
|
|
Dec 4, 2019 |
509 |
| Nivolumab may be beneficial for metastatic cervical cancer. |
Sullivan, Michele |
|
Dec 1, 2019 |
321 |
| CytoDyn wins IRB approval to give leronlimab to triple-negative breast cancer patients on compassionate grounds. |
|
|
Nov 14, 2019 |
481 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Nov 13, 2019 |
2247 |
| Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting. |
|
|
Nov 11, 2019 |
1087 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Nov 6, 2019 |
2247 |
| WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?/U KOJIH BOLESNIKA PRIMIJENITI RADIOTERAPIJU U METASTATSKOM HORMONALNO OSJETLJIVOM KARCINOMU PROSTATE? |
Bisof, Vesna |
Clinical report |
Nov 1, 2019 |
4001 |
| WHICH PATIENTS WILL BENEFIT MOST FROM DOCETAXEL ADDITION TO ANDROGEN DEPRIVATION THERAPY (ADT) IN METASTATIC CASTRATE-SENSITIVE PROSTATE CANCER (MCSPC)?/U KOJIH BOLESNIKA PRIMIJENITI HORMONSKU TER APIJU + DOCETAKSEL. |
Gamulin, Marija; Bebek, Marko; Gnjidic, Milena |
Disease/Disorder overview |
Nov 1, 2019 |
1082 |
| CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER/IZAZOVI MANIPULIRANJA IMUNOLOSKIM SUSTAVOM U SVRHU LIJECENJA RAKA PROSTATE. |
Samija, Ivan; Frobe, Ana |
|
Nov 1, 2019 |
3409 |
| Establishment of primary human epithelial ovarian cancer cells and their application to cytotoxicity assessment. |
Wang, Chun-Kai; Lin, Cheng-Kuo; Huang, Li-Chun; Chou, Ssu-Jen; Lin, Chi-Kang; Chang, Cheng-Chang |
Disease/Disorder overview |
Nov 1, 2019 |
2362 |
| Neoadjuvant chemotherapy in combination with surgery in the treatment of local advanced breast cancer. |
Haixia Zhao, Jinying Zhang, Yanxia Lu and Jihai Jin |
|
Oct 31, 2019 |
3589 |
| Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma. |
Zhao, Lingdi; Yang, Yonghao; Ma, Baozhen; Li, Wei; Li, Tiepeng; Han, Lu; Zhang, Yong; Shang, Yi-Man; |
Clinical report |
Oct 31, 2019 |
6049 |
| Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. |
Giuffrida, Dario; Giuffrida, Raffaella; Puliafito, Ivana; Vella, Veronica; Memeo, Lorenzo; Puglisi, |
|
Oct 31, 2019 |
4826 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Oct 30, 2019 |
1843 |
| Bristol-Myers Squibb UK (NYSE: BMY) - European Commission Approves Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of Lymph Nodes or Metastatic Disease Who Have Undergone Complete Resection -- 24/10/2019. |
|
|
Oct 29, 2019 |
408 |
| Prognostic Factors and Survival Outcome of Whole Brain Radiotherapy in Metastatic Brain Cancer- A Single Regional Cancer Centre Experience in North India. |
Thakur, Purnima; Sharma, Aman; Gupta, Manish; Dhiman, Anupama; Sharma, Jyoti |
|
Oct 28, 2019 |
3686 |
| Oncolytics Biotech's therapy shows 11 month improvement in overall survival in metastatic breast cancer patients. |
|
|
Oct 25, 2019 |
135 |
| EduCare Announces New Recurrent and Metastatic Breast Cancer Treatment Handbook. |
|
|
Oct 24, 2019 |
469 |
| JAMA Oncology Publishes Analysis of Patients with Prior Gastrectomy Treated with Lonsurf. |
|
|
Oct 23, 2019 |
984 |
| Daiichi Sankyo Company, Limited - [Fam-] Trastuzumab Deruxtecan (DS-8201) Granted FDA Priority Review for Treatment of Patients with HER2 Positive Metastatic Breast Cancer -- 17/10/2019. |
|
|
Oct 22, 2019 |
340 |
| AstraZeneca (NYSE: AZN) - Trastuzumab deruxtecan granted FDA Priority Review for treatment of patients with HER2-positive metastatic breast cancer -- 17/10/2019. |
|
|
Oct 21, 2019 |
310 |
| Eli Lilly & Company (NYSE: LLY) - Lilly Announces Phase 3 Study in Patients with Metastatic Pancreatic Cancer Did Not Meet Primary Endpoint of Overall Survival -- 16/10/2019. |
|
|
Oct 21, 2019 |
492 |
| Seattle Genetics (NASDAQ: SGEN). |
|
|
Oct 17, 2019 |
1994 |
| Immutep reports efficacy data for TACTI-mel Phase 1 clinical study. |
|
|
Oct 15, 2019 |
273 |
| Sanofi - New England Journal of Medicine publishes data showing improved survival with Jevtana[R] (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer - 30/9/2019. |
|
|
Oct 10, 2019 |
323 |
| Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Niraparib for the Treatment of Metastatic Castration-Resistant Prostate Cancer -- 3/10/2019. |
|
|
Oct 7, 2019 |
583 |
| Sanofi - New England Journal of Medicine publishes data showing improved survival with Jevtana[R] (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer -- 30/9/2019. |
|
|
Oct 2, 2019 |
323 |
| What is the Diagnostic Performance of 18F-FDG-PET/MRI in the Detection of Bone Metastasis in Patients with Breast Cancer? |
Celebi, Filiz |
|
Oct 1, 2019 |
3064 |
| AstraZeneca (NYSE: AZN) - Lynparza more than doubled the time without radiographic disease progression in patients with BRCA1/2- or ATM-mutated metastatic castration-resistant prostate cancer -- 30/9/2019. |
|
|
Oct 1, 2019 |
1134 |
| AstraZeneca Data Shows Tagrisso as the Only 1st-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer to Deliver a Median Overall Survival of More Than Three Years. |
|
|
Oct 1, 2019 |
580 |
| Roche's Satralizumab Achieves Positive Phase III Results in NMOSD: Merck KGaA's tepotinib granted Breakthrough Designation in non-small cell lung cancer. |
|
|
Oct 1, 2019 |
1712 |
| Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. |
Fei, Fei; Zhang, Mingqing; Li, Bo; Zhao, Lizhong; Wang, Hui; Liu, Lina; Li, Yuwei; Ding, Po; Gu, Yan |
|
Sep 30, 2019 |
8468 |
| Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the Liver. |
Velayati, Sara; Erinjeri, Joseph P.; Brody, Lynn A.; Ziv, Etay; Boas, Franz E.; Brown, Karen T.; Cov |
|
Sep 30, 2019 |
4002 |
| Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy". |
Cho, Edwin; Ballman, Karla; Chen, James; Dickson, Mark A.; George, Rashmi Chugh Suzanne; Okuno, Scot |
Correction notice |
Sep 30, 2019 |
359 |
| Tagrisso is the only 1st-line treatment for EGFR-mutated non-small cell lung cancer to deliver a median overall survival of more than three years. |
|
|
Sep 30, 2019 |
2054 |
| Lynparza more than doubled the time without radiographic disease progression in patients with BRCA1/2- or ATM-mutated metastatic castration-resistant prostate cancer. |
|
|
Sep 30, 2019 |
900 |
| Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl. |
Shindorf, Mackenzie L.; Chaudhuri, Prabir K. |
|
Sep 30, 2019 |
1777 |
| Response of Leptomeningeal Metastases in EGFR-Mutated Non-Small-Cell Lung Cancer to Afatinib in the Absence of Radiotherapy. |
Llinas-Quintero, Nestor; Gonzalez-Hoyos, David; Yepes, Andres; Herrera, Diego A.; Pelaez-Arroyave, S |
|
Sep 30, 2019 |
3099 |
| Prolonged Treatment Response to Pembrolizumab in a Patient with Pretreated Metastatic Colon Cancer and Lynch Syndrome. |
Keating, Matthew; Giscombe, Lisa; Tannous, Toufic; Hartshorn, Kevan |
|
Sep 30, 2019 |
2638 |
| Daiichi Sankyo Company, Limited - Daiichi Sankyo Advances [Fam-] Trastuzumab Deruxtecan (DS-8201) in Japan with Regulatory Submission in HER2 Positive Metastatic Breast Cancer -- 9/9/2019. |
|
|
Sep 10, 2019 |
1348 |
| Puma's Breast Cancer Drug Accorded Orphan Drug Designation For Brain Metastases. |
|
|
Sep 4, 2019 |
347 |
| Cancer care investigation; DGRI patient's complaint upheld MARC MCLEAN. |
|
|
Sep 3, 2019 |
390 |
| FDA grants orphan status to Puma's Nerlynx for brain metastases. |
|
|
Sep 3, 2019 |
193 |
| The Effect of Transarterial Y-90 Microsphere Treatment on Biochemical Parameters in Liver Tumors/Karaciger Tumorlerinde Transarteriyel Y-90 Mikrokure Tedavisinin Biyokimyasal Parametreler Uzerine Etkisi. |
Yilmaz, Burcak; Gundogan, Cihan |
|
Sep 1, 2019 |
3454 |
| Registry study results support baseline imaging for all patients. |
Bosworth, Ted |
Clinical report |
Sep 1, 2019 |
531 |
| Ocular Iridociliary Adenoma in a Congo African Grey Parrot (Psittacus erithacus). |
Thielen, Lauren E.; Sledge, Dodd G.; Hess, Laurie |
|
Sep 1, 2019 |
3590 |
| Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital. |
Zahid, Khawaja F.; Kumar, Shiyam; Bimani, Khalid Al-; Ahmed, Tanweer; Ajmi, Adil Al-; Burney, Ikram |
|
Sep 1, 2019 |
5101 |
| Nektar Therapeutics and Bristol-Myers Squibb were granted Breakthrough Therapy Designation by the FDA for investigational agent bempegaldesleukin (NKTR-214) in combination with Bristol-Myers Squibb's Opdivo (nivolumab) for the treatment of patients with Previously untreated unresectable or metastatic melanoma. |
|
Clinical report |
Sep 1, 2019 |
194 |
| Comparison of Treatment Outcomes in Patients with Rectal Cancer. |
Erdis, Eda; Yucel, Birsen |
|
Sep 1, 2019 |
5261 |
| Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience. |
Demirsoy, Ugur; Corapcioglu, Funda; Karadogan, Meriban |
|
Sep 1, 2019 |
3027 |
| A Retrospective Case Series of Synovial Sarcoma of the Upper Extremity. |
Post, J.; Houdek, M.; Folpe, A.L.; Kakar, S.K.; Wilke, B.K. |
|
Aug 31, 2019 |
4515 |
| Emerging Risk Profile of Lung Cancer Therapy: Diffuse Alveolar Hemorrhage from Osimertinib. |
Forte, Michael J.; Sangani, Rahul G. |
|
Aug 31, 2019 |
2686 |
| Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma. |
Sadagopan, Narayanan; Devoe, Craig |
|
Aug 31, 2019 |
1728 |
| Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. |
Swami, Umang; Monga, Varun; Bossler, Aaron D.; Zakharia, Yousef; Milhem, Mohammed |
|
Aug 31, 2019 |
3740 |
| Association of ESR1 Mutations and Visceral Metastasis in Patients with Estrogen Receptor-Positive Advanced Breast Cancer from Brazil. |
Reinert, Tomas; Coelho, Guilherme Portela; Mandelli, Jovana; Zimermann, Edineia; Zaffaroni, Facundo; |
Clinical report |
Aug 31, 2019 |
3658 |
| Physical Activity, Overall Survival Not Linked in Metastatic CRC; Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events. |
|
|
Aug 28, 2019 |
278 |
| Pfizer Inc. (NYSE: PFE) - U.S. FDA Grants Xtandi[R] (Enzalutamide) Application Priority Review For The Treatment Of Men With Metastatic Hormone-Sensitive Prostate Cancer -- 21/8/2019. |
|
|
Aug 27, 2019 |
559 |
| Astellas Pharma Inc. - U.S. FDA Grants XTANDI[R] (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer - 21/8/2019. |
|
|
Aug 27, 2019 |
546 |
| US FDA Grants XTANDI Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Aug 23, 2019 |
396 |
| Astellas Pharma Inc. - U.S. FDA Grants XTANDI[R] (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer -- 21/8/2019. |
|
|
Aug 22, 2019 |
547 |
| Astellas Pharma and Pfizer submit sNDA for XTANDI for treating metastatic hormone-sensitive prostate cancer. |
|
|
Aug 22, 2019 |
328 |
| Astellas Pharma and Pfizer submit sNDA for XTANDI for treating metastatic hormone-sensitive prostate cancer. |
|
|
Aug 22, 2019 |
324 |
| Hepatitis C and three cancers now covered on basic plan in Dubai. |
|
|
Aug 16, 2019 |
600 |
| Vascular Endothelial Growth Factor (VEGF) Expression in Oral Cancer and its Correlation with Clinico-Pathological Parameters-A Prospective Study. |
Singhal, Ashish; Hadi, Rahat; Mahajan, Charu; Husain, Nuzhat |
Clinical report |
Aug 5, 2019 |
3208 |
| Cutaneous Basal Cell Carcinoma with Bone Metastases: An Orthopaedic Case Report. |
Fram, Brianna R.; Strony, John; Jagannathan, Geetha; Brown, Scot A. |
|
Jul 31, 2019 |
3203 |
| Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US. |
Kawai, Alison Tse; Martinez, David; Saltus, Catherine W.; Vassilev, Zdravko P.; Soriano-Gabarro, Mon |
|
Jul 31, 2019 |
4312 |
| Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital. |
Zhang, Yang; Huang, Zhigang; Gross, Neil; Fang, Jugao; Chen, Xiaohong; Chen, Xuejun; Hou, Lizhen; Li |
|
Jul 31, 2019 |
2399 |
| Lonsurf Receives Positive Opinion from CHMP in the EU for Patients with Previously Treated Metastatic Gastric Cancer. |
|
|
Jul 30, 2019 |
831 |
| Delcath Systems announces results of single center study of PHP Therapy. |
|
|
Jul 22, 2019 |
375 |
| Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Patients with Advanced Solid Tumors. |
|
|
Jul 16, 2019 |
1007 |
| Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study. |
Comert, Gunsu Kimyon; Turkmen, Osman; Boyraz, Gokhan; Yalcin, Ibrahim; Altin, Duygu; Karalok, Alper; |
|
Jul 1, 2019 |
4940 |
| Hepatoid Carcinoma of the Ovary: Clinical, Histopathologic, and Immunophenotypic Features. |
Acosta, Andres M.; Pins, Michael R. |
|
Jul 1, 2019 |
6042 |
| Overview of Patients with Multiple Primary Tumors During Eighty-four Months Follow-up: A Single Center Experience/Seksen-dort Aylik Izlemde Coklu Primer Tumor Tanili Hastalarimiza Bakis: Tek Merkez Deneyimi. |
Mermut, Ozlem; Gursu, Riza Umar |
Disease/Disorder overview |
Jul 1, 2019 |
3157 |
| Surgical Treatment of a Patient with a Solitary Thyroid Metastasis from Primary Sigmoid Adenocarcinoma: A Case Report and Literature Review. |
Yamahara, Kohei; Moriki, Toshiaki; Katsura, Yuki; Lee, Kana; Ikegami, Satoshi |
|
Jun 30, 2019 |
2860 |
| High Expression and Clinical Significance of Elafin in Colorectal Cancer. |
Liu, Yun; Tian, Yu; Wu, Ting; Dai, Yun; Wang, Weihong; Teng, Guigen |
|
Jun 30, 2019 |
4325 |
| The Three P's: Parotid, PD-L1, and Pembrolizumab. |
Wiggins, Amanda; Arter, Zhaohui; Kerns, Tamie |
|
Jun 30, 2019 |
1955 |
| Management algorithms for metastatic prostate cancer. |
Malone, Shawn; Shayegan, Bobby; Basappa, Naveen S.; Chi, Kim; Conter, Henry J.; Hamilton, Robert J.; |
|
Jun 27, 2019 |
8597 |
| Xoma's gevokizumab used to dose first patient in cancer study by Novartis. |
|
|
Jun 13, 2019 |
103 |
| LabCorp and Qiagen Launch New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer. |
|
|
Jun 11, 2019 |
470 |
| Lynparza First-Line Maintenance Therapy Nearly Doubled the Time Without Disease Progression or Death in Phase 3 POLO Trial for Patients with Germline BRCA-Mutated Metastatic Pancreatic Cancer. |
|
|
Jun 4, 2019 |
760 |
| Sufferers of cancer given new hope. |
|
|
Jun 3, 2019 |
147 |
| US Merck's Keytruda Demonstrates Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial. |
|
|
Jun 3, 2019 |
383 |
| Erleada Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer. |
|
|
Jun 3, 2019 |
239 |
| Seattle Genetics, Astellas announce data from cohort of EV-201 trial. |
|
|
Jun 3, 2019 |
516 |
| Evaluation of Mandibular Morphometry in the Bisphosphonate Users/Evaluacion de la Morfometria Mandibular en los Usuarios de Bifosfonatos. |
Busra, Tanrikol; Guldane, Magat |
|
Jun 1, 2019 |
7347 |
| Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation. |
Yan, Jingyi; Chen, Didi; Chen, Xiaolei; Sun, Xuecheng; Dong, Qiantong; Hu, Changyuan; Zhou, Feng; Ch |
|
Jun 1, 2019 |
3976 |
| Honokiol and Magnolol Inhibit Growth, Metastasis and Induce Apoptosis in Human Cholangiocarcinoma. |
Songjang, Worawat; Jiraviriyakul, Arunya |
|
Jun 1, 2019 |
6338 |
| Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center. |
Cardi, Maurizio; Sibio, Simone; Di Marzo, Francesco; Lefoche, Francesco; d'Agostino, Claudia; Fonsi, |
|
May 31, 2019 |
5467 |
| Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience. |
Jumayli, Mohammed Al-; Batool, Amna; Middiniti, Akshay; Saeed, Anwaar; Sun, Weijing; Rajabi, Raed Al |
|
May 31, 2019 |
3864 |
| Treatment of Spinal Metastases with Epidural Cord Compression through Corpectomy and Reconstruction via the Traditional Open Approach versus the Mini-Open Approach: A Multicenter Retrospective Study. |
Zhou, Xi; Cui, Haomin; He, Yu; Qiu, Guixing; Zhou, Dongsheng; Liu, Yong |
|
May 31, 2019 |
4784 |
| A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm. |
Zhu, Wang-Yu; Fang, Ke-Xin; He, Jian-Ying; Cui, Ri; Zhang, Yong-Kui; Le, Han-Bo |
Clinical report |
May 31, 2019 |
6090 |
| Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. |
Fazel, Mahdieh; Jedlowski, Patrick M. |
|
May 31, 2019 |
1815 |
| Anti-Invasion and Antimetastatic Effects of Porcine Recombinant NK-lysin on SMMC-7721 Human Hepatocellular Carcinoma Cells. |
Fan, Kuohai; Du, Wenjuan; Wang, Zhirui; Khan, Ajab; Li, Hongquan; Jiang, Junbing |
|
May 31, 2019 |
3803 |
| US Merck Provides Update on Phase 3 KEYNOTE-119 Study of Keytruda Monotherapy in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer. |
|
|
May 22, 2019 |
437 |
| Breast Carcinoma Metastasis to the Medial Rectus Muscle: Case Report. |
Kiziloglu, Ozge Yabas,; Turkoz, Fatma Paksoy; Gedar, Ozgun Melike Totuk; Mestanoglu, Mert; Yapicier, |
|
May 1, 2019 |
1823 |
| Isolated Unilateral Infiltrative Optic Neuropathy in a Patient with Breast Cancer. |
Aghdam, Kaveh Abri; Zand, Amin; Sanjari, Mostafa Soltan |
|
May 1, 2019 |
1783 |
| Assesment of symptom burden and related factors of patients with lung cancer in a palliative care unit. |
Kizilgoz, Derya; Yesildagli, Havva; Kabalak, Pinar Akin; Cengiz, Tuba Inal; Yilmaz, Ulkii |
Report |
May 1, 2019 |
2298 |
| Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol. |
Wang, Dongying; Zhao, Chunhua; Fu, Li; Liu, Yang; Zhang, Weiyang; Xu, Tianmin |
|
Apr 30, 2019 |
3702 |
| Prognostic Value of [sup.18]F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel. |
Quaquarini, E.; D'Ambrosio, D.; Sottotetti, F.; Gallivanone, F.; Hodolic, M.; Baiardi, P.; Palumbo, |
|
Apr 30, 2019 |
4785 |
| Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience. |
Karivedu, Vidhya; Eldessouki, Ihab; Taftaf, Ahmad; Zhu, Zheng; Makramalla, Abouelmagd; Karim, Nagla |
Clinical report |
Apr 30, 2019 |
5527 |
| Sequential Interventional Management of Osseous Neoplasms via Embolization, Cryoablation, and Osteoplasty. |
Sundararajan, Sri Hari; Calamita, Steven; Girgis, Peter; Ngo, Gregory; Ranganathan, Srirajkumar; Gig |
|
Apr 30, 2019 |
3470 |
| Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG). |
Wang, Kang; Wu, Yu-Tuan; Zhang, Xiang; Chen, Li; Zhu, Wen-Ming; Zhang, Ai-Jie; Zheng, Ke; Yin, Xue-D |
|
Apr 30, 2019 |
9244 |
| Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. |
Fiorentini, Chiara; Grisanti, Salvatore; Cosentini, Deborah; Abate, Andrea; Rossini, Elisa; Berruti, |
|
Apr 30, 2019 |
5933 |
| Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research. |
Koumpa, Foteini Stefania; Xylas, Diamantis; Konopka, Maciej; Galea, Dieter; Veselkov, Kirill; Antoni |
|
Apr 30, 2019 |
18730 |
| Seattle Genetics and Astellas Tout Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Apr 1, 2019 |
731 |
| A RETROSPECTIVE STUDY OF TH.E IMPACT OF RADIATION FRACTIONATION ON PAINFUL BONE METASTASIS. |
Suresh, Kumar K.; Thomas, Flowerlit; Nair, Ajith; Mathew, Mintu; Snigdha, P.P. |
Report |
Apr 1, 2019 |
4957 |
| Tonsillar and Parotid Gland Metastases of Breast Cancer: Two Cases and A Literature Review. |
Cengiz, Abdurrahman Bugra; Comert, Ela; Tuncel, Omit; Dilek, Gulay; Benzer, Emine |
|
Apr 1, 2019 |
1926 |
| Cytogenetic Studies of Chromosome Abnormalities in Thyroid Cancer Patients Before and After Iodine-131 Treatment. |
Oden, Seda; Atasoy, Sezen; Demir, Mustafa; Deviren, Ayhan |
|
Apr 1, 2019 |
3809 |
| European Commission Approves US Merck's Keytruda (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer. |
|
|
Mar 15, 2019 |
497 |
| Celgene Provides Update on Abraxane Combination Therapy in the Treatment of Metastatic Triple-Negative Breast Cancer and Pancreatic Cancer. |
|
|
Mar 14, 2019 |
668 |
| Odonate Therapeutics Initiates CONTESSA 2, a Phase 2 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane. |
|
|
Mar 6, 2019 |
657 |
| DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION ([less than or equal to]18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131). |
Prpic, Marin; Franceschi, Maja; Jukic, Tomislav; Kust, Davor; Dabelic, Nina; Varjacic, Tea; Lucijani |
|
Mar 1, 2019 |
4846 |
| Secondary Prevention of Bone Disease In Men on Androgen Deprivation Therapy For Prostate Cancer: Quality Improvement Through Implementation of Evidence-Based Bone Health Guidelines. |
LaRoche, Mary Jane; Makic, Mary Beth Flynn; Shaw, Kathy |
|
Mar 1, 2019 |
9017 |
| Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study/Ucuncu Basamakta Regorafenib ile Tedavi Edilen Metastatik Kolorektal Kanserli Hastalarin Sonuclari-Cok Merkezli Calisma. |
Sahin, Suleyman; Hacioglu, Muhammet Bekir |
|
Mar 1, 2019 |
3427 |
| Opdivo Plus Yervoy Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Feb 20, 2019 |
544 |
| US Merck Increases Focus on Advanced Prostate Cancer, Expanding Immuno-Oncology Programme with Three New Phase 3 Trials. |
|
|
Feb 15, 2019 |
1895 |
| European Medicines Agency Adopts Positive Opinion for US Merck's Keytruda in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC). |
|
|
Feb 4, 2019 |
430 |
| Pfizer receives positive CHMP opinion for Vizimpro. |
|
|
Feb 1, 2019 |
214 |
| Perspectives in veterinary medicine on the use of cannabinoids as complementary palliative therapy for pain in cancer patients/Perspectivas sobre o uso de canabinoides como terapeutica paliativa complementar da dor em pacientes oncologicos na medicina veterinaria. |
Repetti, Claudia Sampaio Fonseca; Girio, Raul Jose Silva; Friolani, Milena; Barbalho, Sandra Maria |
|
Feb 1, 2019 |
4431 |
| The Role of [.sup.18]F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels/CA-125 Duzeylerinde Artis Olan Over Kanserli Hastalarda Rekurrens Saptamada [.sup.18]F-FDG PET/BT'nin Rolu. |
Cengiz, Arzu; Koc, Zehra Pinar; Kara, Pelin Ozcan; Yurekli, Yakup |
|
Feb 1, 2019 |
3938 |
| False-positive I-131 Uptakes at Pulmonary Wedge-resection Site and Soft Tissue Lateral to the Femoral Heads in a Patient with Papillary Thyroid Carcinoma/Papiller Tiroid Kanserli Bir Hastada Akcigerde Kama-Rezeksiyon Alaninda ve Femur Baslarinin Lateralinde Yumusak Dokuda Yanlis-Pozitif I-131 Tutulumlari. |
Yazici, Bulent; Oral, Aylin; Alcicek, Seyma; Tamsel, Ipek; Akgun, Aysegul |
|
Feb 1, 2019 |
412 |
| A Preliminary Study of Serum Apelin Levels in Patients with Head and Neck Cancer. |
Aktan, Meryem; Ozmen, Hilal Kiziltunc |
|
Feb 1, 2019 |
1787 |
| A Pathologist's Guide to Creating an Informative Report and Improving Patient Care. |
Prats, Mariana Moreno; Sasatomi, Eizaburo; Stevenson, Heather L. |
Report |
Feb 1, 2019 |
4100 |
| Trovagene announces US FDA's may proceed notification for Phase 1b/2 trial of Onvansertib in metastatic colorectal cancer patients. |
|
|
Jan 30, 2019 |
212 |
| Trovagene announces US FDA's may proceed notification for Phase 1b/2 trial of Onvansertib in metastatic colorectal cancer patients. |
|
|
Jan 30, 2019 |
208 |
| THE RELATION BETWEEN CA 125, CECT ABDOMEN & PELVIS AND HISTOPATHOLOGICAL FEATURES IN OVARIAN NEOPLASMS. |
Prakash, S.S.; Antony, Charles Jude; Ashwini B.G. |
Report |
Jan 21, 2019 |
3308 |
| Could Nomograms Used to Identify Non-Sentinel Lymph Node Metastases May Be Valuable in Radiotherapy Planning? |
Cihan, Yasemin Benderli |
Report |
Jan 1, 2019 |
1115 |
| Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy. |
Gasinska, Anna; Biesaga, Beata; Widla, Anna Janecka; Darasz, Zbigniew |
Report |
Jan 1, 2019 |
7615 |
| A Progressed Case of Stewart--Treves Syndrome in a Patient with Chronic Idiopathic Lymphedema in the Lower Extremity. |
Ozdemir, Mehmet; Sultany, Muhammed Sulaiman; Celikkaleli, Ercan; Ozalp, Burhan |
Clinical report |
Jan 1, 2019 |
1397 |
| Portal vein ligation and in situ liver splitting in metastatic liver cancer. |
Aghayeva, Afag; Baca, Bilgi; Atasoy, Deniz; Ferahman, Sina; Uludag, Sezgin; Bilgin, Ismail Ahmet; Be |
Case study |
Dec 1, 2018 |
1772 |
| Breast cancer with intraabdominal metastases. Is surgery necessary? |
Panuta, Andrian; Radu, Iulian; Hutanu, Ionut; Musina, Ana-Maria; Buna-Arvinte, Mihaela; Gavrilescu, |
Report |
Dec 1, 2018 |
3076 |
| Atypical Metastasis to the Head and Neck Region: An Analysis of 11 Patients. |
Sahin, Bayram; Doruk, Can; Celik, Mehmet; Ozturk, Erkan; Gunes, Selcuk; Kiyak, Okkes Erkan |
Report |
Dec 1, 2018 |
3948 |
| DIFERANSIYE TIROID KANSERLERINDE RADYOAKTIF IYOT TEDAVISI SONRASI GORUNTULEME: SPECT-BT GORUNTULEMENIN PLANAR GORUNTULEMEYE KATKISI/POST-THERAPY IMAGING AFTER RADIOACTIVE IODINE THERAPY FOR DIFFERENTIATED THYROID CANCER: THE CONTRIBUTION OF SPECT-CT IMAGING TO PLANAR IMAGING. |
SImsek, Duygu Has; Sanli, Yasemin; Kuyumcu, Serkan; Yilmaz, Ebru; Ozkan, Zeynep Gozde; Turkmen, Cune |
|
Dec 1, 2018 |
4782 |
| A Rarely Seen Pathology "Intramedullary Spinal Metastasis"; Clinical Series of Five Patients in a Single Institution/Nadir Gorulen Bir Patoloji "Intrameduller Spinal Metastaz"; Tek Bir Saglik Merkezinde Bes Hastalik Klinik Bir Seri. |
Akyuva, Yener; Karadag, Nese; Onal, Cagatay |
Clinical report |
Dec 1, 2018 |
5317 |
| FDA Grants Priority Review to Genentech's Tecentriq in Combination with Abraxane for the Initial Treatment of People with PD-L1-Positive, Metastatic Triple-Negative Breast Cancer. |
|
|
Nov 20, 2018 |
271 |
| Systemic Therapy in Metastatic Castration-Resistant Prostate Cancer/Metastatik Kastrasyona Direncli Prostat Kanserinde Sistemik Tedavi. |
Dulgar, Ozgecan; Yilmaz, Mesut; Tural, Deniz |
|
Nov 1, 2018 |
2940 |
| Possible Role of Ga-68 PSMA PET/CT in Evaluation of Systemic Treatment Response in Patients with Metastatic Prostate Cancer/Metastatik Prostat Kanserli Hastalarda, Ga-68 Prostat Spesifik Membran Antijen PET/BT'nin Sistemik Tedavi Yaniti Degerlendirilmesinde Olasi Rolu. |
Sivrikoz, Ilknur Ak |
|
Nov 1, 2018 |
4357 |
| Ra-223 Alpha Treatment in Prostate Cancer/Prostat Kanserinde Ra-223 Alfa Tedavi. |
Selcuk, Nalan Alan; Yencilek, Faruk |
|
Nov 1, 2018 |
2165 |
| Lu-177 Prostate Specific Membrane Antigen Therapy of Metastatic Castration Resistant Prostate Cancer/Prostat Kanserinde Lu-177 Prostat Spesifik Membran Antijeni Tedavisi. |
Demirci, Emre; Kabasakal, Levent |
|
Nov 1, 2018 |
3341 |
| Orion and Bayer announce completion of phase III trial of darolutamide; primary end point met. |
|
|
Oct 25, 2018 |
460 |
| Orion and Bayer announce completion of phase III trial of darolutamide; primary end point met. |
|
|
Oct 25, 2018 |
461 |
| Orion and Bayer announce completion of phase III trial of darolutamide; primary end point met. |
|
|
Oct 25, 2018 |
456 |
| Opdivoin Combination with Yervoy Results in Significantly Longer Treatment-Free Survival in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Oct 25, 2018 |
187 |
| Using light to destroy metastatic breast cancer. |
|
|
Oct 23, 2018 |
293 |
| Phase III Lonsurf Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer, According to Servier and Taiho Oncology. |
|
|
Oct 23, 2018 |
952 |
| Opdivo Plus Low-Dose Yervoy Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer. |
|
|
Oct 23, 2018 |
577 |
| Athenex: 11 patients achieved partial remission in Oraxol trial. |
|
|
Oct 22, 2018 |
135 |
| Genentech's Tecentriq in Combination with Abraxane Improves Outcomes as an Initial Treatment for People with PD-L1-Positive Metastatic Triple-Negative Breast Cancer. |
|
|
Oct 22, 2018 |
159 |
| Merck's Keytruda in Combination with Pfizer's Inlyta (axitinib) Significantly Improved Overall Survival and Progression-free Survival as First-Line Therapy for Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Oct 19, 2018 |
513 |
| Progression-Free Survival Extended. |
|
|
Oct 1, 2018 |
278 |
| The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome. |
Cakar, Burcu; Surmeli, Zeki; Oner, Pinar Gursoy; Yelim, Elif Sila; Karabulut, Bulent; Uslu, Ruchan |
Report |
Oct 1, 2018 |
4830 |
| The Significance of Extent of Extracapsular Extension in Patients with T1-2 and N1 Breast Cancer. |
Kanyilmaz, Gul; Findik, Siddika; Yavuz, Berrin Benli; Aktan, Meryem |
Report |
Oct 1, 2018 |
4125 |
| Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy. |
Liu, Shuai; Chen, Peng; Liu, Yan-Wei; Gu, Xue-Nan; Qiu, Xiao-Guang; Li, Bo |
Report |
Oct 1, 2018 |
4742 |
| Nivolumab plus ipilimumab effective in melanoma brain metastases. |
Bowser, Andrew D. |
|
Oct 1, 2018 |
634 |
| Infantile choriocarcinoma with cutaneous, liver, and lung metastases. |
Dance, Logan; Patel, Apurvi; Patel, Mittun; Towbin, Alexander J.; Towbin, Richard |
|
Oct 1, 2018 |
978 |
| Role of palliative CSF diversion in patients with intracranial metastatic disease and symptomatic hydrocephalus. |
|
|
Sep 30, 2018 |
1345 |
| I'mstillhereafter all that bloody fighting but I WONDERIFI would be if I hadn'tgot asecond opinion; CANCER MUM ON SERIES OF TREATMENT FAILURES Former nurse Anne says more must be done to monitor patients for disease. |
|
|
Sep 27, 2018 |
887 |
| European Commission Approves Merck's Keytruda in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC, with No EGFR or ALKGenomic Tumor Aberrations. |
|
|
Sep 10, 2018 |
170 |
| A Rare Case of the Urinary Bladder: Small Cell Carcinoma/Mesanede Nadir Gorulen Olgu: Kucuk Hucreli Karsinom. |
Kervancioglu, Enis; Dirim, Ayhan; Akcay, Eda Yilmaz |
Report |
Sep 1, 2018 |
1198 |
| Survival better for patients with melanoma brain metastases. |
Pass, Will |
|
Sep 1, 2018 |
358 |
| Sonic hedgehog inhibitors have mixed efficacy for advanced BCC. |
Osterweil, Neil |
|
Sep 1, 2018 |
572 |
| Bilateral Malignant Seminoma With Ventricular Metastasis in a Bald Eagle (Haliaeetus leucoceplialus). |
Sullivan, Patrick J.; Fasina, Olufemi O.; Cushing, Andrew C. |
|
Sep 1, 2018 |
2989 |
| Distribution of Metastatic Nodes in N0-1 Patients with Tonsillar Squamous Cell Carcinoma and Its Implications for Selective Neck Dissection. |
Kohler, Hugo Fontan; Franzi, Sergio Altino; Soares, Fernando Augusto; Torloni, Humberto; Kowalski, L |
Report |
Sep 1, 2018 |
3808 |
| Two cases of pediatric epithelioid sarcoma of the hand and coverage with Integra[R]. |
Nastasa, Mihaela; Casoli, Vincent |
Clinical report |
Sep 1, 2018 |
3319 |
| Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets; Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases. |
|
Clinical report |
Aug 22, 2018 |
252 |
| Metastatik Mide Karsinomlu Hastalarda Periton Metastazi Varliginin Prognostik Etkisi/Prognostic Effect of Peritoneal Metastasis in Patients with Metastatic Gastric Carcinoma. |
Demirci, Nebi Serkan |
|
Aug 1, 2018 |
5063 |
| Literature Review & Commentary. |
Gaby, Alan R. |
|
Aug 1, 2018 |
2412 |
| The Clinical Characteristics and Surgical Outcomes of Carcinoma of the External Auditory Canal: A Multicenter Study. |
Park, Jung Mee; Kong, Ji Sun; Chang, Ki Hong; Jun, Beom Cho; Jeon, Eun Ju; Park, So Young; Park, Shi |
|
Aug 1, 2018 |
4570 |
| Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. |
Yokom, Daniel W.; Stewart, John; Alimohamed, Nimira S.; Winquist, Eric; Berry, Scott; Hubay, Stacey; |
Report |
Aug 1, 2018 |
6007 |
| FDA Grants Breakthrough Therapy Designation for Lenvima/Keytruda Combination as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma. |
|
|
Aug 1, 2018 |
756 |
| Clinicopathological prognostic factors of oral squamous cell carcinoma: An experience of a tertiary care hospital. |
|
Report |
Jul 31, 2018 |
2869 |
| Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA. |
|
|
Jul 31, 2018 |
1616 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
314 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
315 |
| Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. |
|
|
Jul 12, 2018 |
310 |
| Seattle Genetics announces results of two Phase 1b trials. |
|
Financial report |
Jul 11, 2018 |
319 |
| LYNPARZA approved in Japan for BRCA-mutated metastatic breast cancer. |
|
|
Jul 2, 2018 |
200 |
| RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients. |
Keup, Corinna; Mach, Pawel; Aktas, Bahriye; Tewes, Mitra; Kolberg, Hans-Christian; Hauch, Siegfried; |
|
Jul 1, 2018 |
5781 |
| Sister Mary Joseph's Nodule: A short compilation. |
Ergen, Selcuk |
Letter to the editor |
Jul 1, 2018 |
843 |
| Lonsurf Trial Shows Improved Overall Survival in Patients with Metastatic Gastric Cancer. |
|
Clinical report |
Jun 27, 2018 |
251 |
| A 20 YEARS' EXPERIENCE ON GRANULOSA CELL TUMOUR. |
Martin, P. Jovita M.; Kalaichelvi, K.; Lakshminarasimhan; Ramkumar; Dheenadhayalan |
Report |
Jun 25, 2018 |
4199 |
| Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation Given Priority Review Status with FDA. |
|
|
Jun 12, 2018 |
277 |
| KEYNOTE-042 Phase 3 Study of Keytruda as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 Yields Positive Results. |
|
Report |
Jun 7, 2018 |
344 |
| Phase 3 KEYNOTE-407 Study of Keytruda Plus Chemotherapy Shows Increased Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC. |
|
Report |
Jun 7, 2018 |
325 |
| Oral Chemotherapy Tesetaxel Shows a 45% Confirmed Response Rate in Patients with HER2 Negative, HR Positive, Metastatic Breast Cancer. |
|
|
Jun 7, 2018 |
257 |
| Left-Sided Colonic Obstruction Due to Brid Ileus and Coexisting Right Colon Cancer without Palpable Mass/Sol Kolon Kaynakli Brid Ileus ile Seyreden Ele Gelmeyen Sag Kolon Kanseri. |
Beksac, Kemal; Ustuner, Mehmet Akif; Cetin, Bahadir |
Case study |
Jun 1, 2018 |
1509 |
| AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND/NEOBICNO MJESTO PRESADNICE PAPILARNOG KARCINOMA STITNJACE U NADBUBREZNU ZLIJEZDU: PRIKAZ SLUCAJA. |
Blazekovic, Ivan; Jukic, Tomislav; Granic, Roko; Punda, Marija; Franceschi, Maja |
Case study |
Jun 1, 2018 |
1484 |
| Researchers at Cancer Treatment Centers of America' in Suburban Chicago Evaluating Investigational Medication for HER2-Positive Breast Cancer. |
|
Clinical report |
May 24, 2018 |
754 |
| Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. |
|
|
May 21, 2018 |
202 |
| Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. |
|
|
May 21, 2018 |
198 |
| Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. |
|
|
May 14, 2018 |
306 |
| Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. |
|
|
May 11, 2018 |
306 |
| A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. |
Hosseini, Mohammad Amin; Mohamadianpanah, Mohammad; Zare-Bandeamiri, Mohammad; Mosleh-Shirazi, Moham |
Report |
May 1, 2018 |
3067 |
| Inaugural Chicago Metsquerade on May 11 - A Fundraiser for Stage IV Breast Cancer Research. |
|
|
May 1, 2018 |
553 |
| CT fluoroscopy-guided percutaneous osteoplasty with or without radiofrequency ablation in the treatment of painful extraspinal and spinal bone metastases: technical outcome and complications in 29 patients. |
Burgard, Caroline A.; Dinkel, Julien; Strobl, Frederik; Paprottka, Philipp M.; Schramm, Nicolai; Rei |
Report |
May 1, 2018 |
6205 |
| Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy. |
Haselmann, Verena; Gebhardt, Christoffer; Brechtel, Ingrid; Duda, Angelika; Czerwinski, Claudia; Suc |
|
May 1, 2018 |
8781 |
| The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab. |
|
|
Apr 11, 2018 |
1280 |
| Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. |
Karakiewicz, Pierre I.; Zaffuto, Emanuele; Kapoor, Anil; Basappa, Naveen S.; Bjarnason, Georg A.; Bl |
Report |
Apr 6, 2018 |
4565 |
| Nerlynx (neratinib) in Combination With Capecitabine or Paclitaxel Included in NCCN Guidelines as Treatment Option for Patients With Breast Cancer Brain Metastases. |
|
|
Apr 5, 2018 |
183 |
| Medicare Issues Local Draft Coverage Supporting Use of Cell-based Liquid Biopsy Test in Patients with Metastatic CRPC. |
|
|
Apr 3, 2018 |
313 |
| Risky Alternatives. |
|
Brief article |
Apr 1, 2018 |
143 |
| Giant Cell Tumor of the Temporal Bone and Skull Base: A Case Report. |
Kaya, Isa; Benzer, Murat; Turhal, Goksel; Gode, Sercan; Bilgen, Cem; Kirazli, Tayfun |
|
Apr 1, 2018 |
1764 |
| Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast. |
Guven, Hikmet Erhan; Kulturoglu, Mahmut Onur; GulCelik, Mehmet Ali; Ozaslan, Cihangir |
Report |
Apr 1, 2018 |
2684 |
| Late breast cancer recurrence with bone marrow metastases and acute pulmonary hypertension. |
Atwal, Dinesh; Ramos, Jeanette M.; Makhoul, Issam |
Clinical report |
Apr 1, 2018 |
1371 |
| Dusuk Doz Radyoterapi Volumlerinin Akciger Kanseri Hastalarinda Yasam Uzerine Etkileri/Effects of Low-Dose Radiation on the Survival of Lung Cancer Patients. |
Kiziltan, Huriye Senay; Mayadagli, Alpaslan; Eris, Ali Hikmet; Kablan, Ozgur; Turan, Sezgi; Evren, E |
Report |
Apr 1, 2018 |
1993 |
| Axillary Metastatic Breast Cancer and Tuberculous Lymphadenopathy in Supraclavicular Region. |
Sarica, Ozgur; Agalar, Fatih; Berberoglu, Kezban |
|
Apr 1, 2018 |
1808 |
| Bristol-Myers Squibb Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Certain Metastatic Colorectal Cancer Patients Accepted by US FDA for Priority Review. |
|
|
Mar 29, 2018 |
280 |
| FDA Grants Breakthrough Therapy Designation to Seattle Genetics and Astellas for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. |
|
|
Mar 28, 2018 |
320 |
| Astex Collaborator Janssen Receives US FDA Breakthrough Therapy Designation for Erdafitinib for Metastatic Urothelial Cancer. |
|
|
Mar 20, 2018 |
235 |
| Pulmonary Metastasis of a Gigantic Cystosarcoma Phyllodes of the Breast. |
Gao, Yan-Hong; Xiang, Hui-Juan; Zhu, Jian; Duan, Yun; Zhou, Pei |
Clinical report |
Mar 18, 2018 |
771 |
| Primary Pulmonary Germ Cell Tumor with Bone Metastasis. |
Li, Tong-Tong; Yan, Xu; Zhou, Tong; Liu, Ying; Yu, Zhen-Xiang |
Clinical report |
Mar 18, 2018 |
1175 |
| Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. |
|
|
Mar 16, 2018 |
253 |
| Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. |
|
|
Mar 16, 2018 |
249 |
| DISTAL PANCREATECTOMY IN THE SURGICAL TREATMENT OF PANCREATIC CANCER--A STUDY. |
Choudhury, Purujit |
Report |
Mar 5, 2018 |
2868 |
| Sorrento Therapeutics says CAR-T cell therapy demonstrates therapeutic activity. |
|
|
Mar 5, 2018 |
387 |
| First Patient Dosed in Merrimack Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer. |
|
Clinical report |
Mar 1, 2018 |
257 |
| Sustained Ventricular Tachycardia Secondary to Cardiac Metastasis of Lung Cancer. |
Li, Ying-Ying; Wang, Hua; Cui, Ya-Dong; Liu, Hang-Yu; Yang, Jie-Fu |
Case study |
Mar 1, 2018 |
1192 |
| STEREOLOGICAL ANALYSIS OF ANDROGEN RECEPTORS IN PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA/STEREOLOSKA ANALIZA ANDROGENIH RECEPTORA KOD KARCINOMA I BENIGNE HIPERPLAZIJE PROSTATE. |
Dajko, Sandra Trivunic; Bogdanovic, Jovo; Vojinov, Sasa; Visnjic, Bojana Andrejic |
Report |
Mar 1, 2018 |
4075 |
| Primary splenic angiosarcoma diagnosed after splenectomy for spontaneous rupture. |
Ozcan, Bans; Cevener, Metin; Kargi, Aysegul Odabasi; Dikici, Hilmi; Yildiz, Akin; Ozdogan, Mustafa; |
|
Mar 1, 2018 |
1412 |
| Obesity Linked to Improved Survival in Metastatic Melanoma; Survival benefit limited to male patients receiving targeted therapy, immunotherapy. |
|
|
Feb 21, 2018 |
272 |
| Janssen Files MAA for Apalutamide for Treatment of High-Risk Non-Metastatic CRPC in Europe. |
|
|
Feb 14, 2018 |
282 |
| Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. |
Brand, M.; Gaylard, P.; Ramos, J. |
Report |
Feb 1, 2018 |
3512 |
| Testosterone suppression in the treatment of recurrent or metastatic prostate cancer--A Canadian consensus statement. |
Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret |
Report |
Feb 1, 2018 |
6012 |
| Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. |
Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret |
|
Feb 1, 2018 |
1364 |
| A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. |
Khalaf, Daniel Joseph; Aviles, Claudia M.; Azad, Arun A.; Sunderland, Katherine; Todenhofer, Tilman; |
Report |
Feb 1, 2018 |
4584 |
| Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients. |
Markou, Athina; Lazaridou, Marifili; Paraskevopoulos, Panagiotis; Chen, Shukun; Swierczewska, Monika |
|
Feb 1, 2018 |
6322 |
| FDA Grants Synthon Fast Track Designation for Anti-HER2 ADC for Pre-treated HER2-positive Metastatic Breast Cancer. |
|
|
Jan 29, 2018 |
208 |
| Opdivo plus Yervoy Shows 55% ORR at 13.4 Months in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. |
|
|
Jan 22, 2018 |
328 |
| Amgen and Allergan's Mvasi for certain cancers approved in Europe. |
|
|
Jan 18, 2018 |
114 |
| Eisai and Merck & Co. Receive Breakthrough Therapy Designation from U.S. FDA for LENVIMA and KEYTRUDA. |
|
|
Jan 9, 2018 |
1432 |
| Papillary Carcinoma of Thyroid with Nasal Cavity Metastases: A Case Report. |
Pourseirafi, Saeid; Shishehgar, Mahmood; Ashraf, Mohammad Javad; Faramarzi, Mohammad |
Case study |
Jan 1, 2018 |
1640 |
| Amgen's sBLA for XGEVA (denosumab) to expand the currently approved indication for the prevention of skeletal-related events in patients with bone metastases from solid tumors, has been approved to include multiple myeloma. |
|
|
Jan 1, 2018 |
217 |
| Transrectal ultrasound-guided prostate biopsies vs. magnetic resonance imaging ultrasound fusion targeted biopsies: Who are the best candidates? |
Bey, Elsa; Gaget, Olivier; Descotes, Jean-Luc; Franquet, Quentin; Rambeaud, Jean-Jacques; Long, Jean |
Report |
Jan 1, 2018 |
3252 |
| Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. |
Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo |
Report |
Jan 1, 2018 |
3753 |
| Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. |
Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer |
Clinical report |
Jan 1, 2018 |
1729 |
| Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. |
Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, |
Report |
Jan 1, 2018 |
5456 |
| A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer. |
Voutsadakis, Ioannis A. |
Report |
Jan 1, 2018 |
5289 |
| The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study. |
Menon, Riju; Nair, C. Gopalakrishnan; Babu, Misha; Jacob, Pradeep; Krishna, G. Praveen |
|
Jan 1, 2018 |
3402 |
| Increased Rate of Incidental Colorectal Malignant Polyps: A Single-Center Experience. |
Buchbjerg, T.; Kroijer, R.; Najami, I. Al-; Hansen, K. Urth; Baatrup, G. |
|
Jan 1, 2018 |
3519 |
| Gender-Specific Risk of Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. |
Sun, Yushi; Lv, Hongjun; Zhang, Shaoqiang; Bai, Yanxia; Shi, Bingyin |
|
Jan 1, 2018 |
5092 |
| Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors. |
Di Giacinto, Paola; Rota, Francesca; Rizza, Laura; Campana, Davide; Isidori, Andrea; Lania, Andrea; |
|
Jan 1, 2018 |
8990 |
| Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. |
Kurtz, Florian; Struller, Florian; Horvath, Philipp; Solass, Wiebke; Bosmuller, Hans; Konigsrainer, |
|
Jan 1, 2018 |
5253 |
| Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases. |
Abdel-Rahman, Omar; Cheung, Winson Y. |
|
Jan 1, 2018 |
3042 |
| 2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations. |
Halkia, Evgenia; Chrelias, George; Chrelias, Charalambos; Esquivel, Jesus |
|
Jan 1, 2018 |
4922 |
| Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy. |
Ito, Yasuhiro; Abe, Yuta; Egawa, Tomohisa; Kitago, Minoru; Itano, Osamu; Kitagawa, Yuko |
|
Jan 1, 2018 |
5066 |
| Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer. |
Yoshuantari, Naomi; Heriyanto, Didik Setyo; Hutajulu, Susanna Hilda; Kurnianda, Johan; Ghozali, Ahma |
|
Jan 1, 2018 |
5430 |
| The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent. |
Jutzy, Jessica M.S.; Lemons, Jeffrey M.; Luke, Jason J.; Chmura, Steven J. |
Report |
Jan 1, 2018 |
6191 |
| Rate of Clinical Complete Response for 1 Year or More in Bone-Metastatic Breast Cancer after Comprehensive Treatments including Autologous Formalin-Fixed Tumor Vaccine. |
Kuranishi, Fumito; Imaoka, Yuki; Sumi, Yuusuke; Uemae, Yoji; Yasuda-Kurihara, Hiroko; Ishihara, Take |
Report |
Jan 1, 2018 |
6271 |
| Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma. |
Hammamy, Riyadh Ali Mohammed; Farooqui, Khalid; Ghadban, Wisam |
Case study |
Jan 1, 2018 |
1720 |
| Adolescent and Young Adult Testicular Germ Cell Tumors: Special Considerations. |
Saltzman, Amanda F.; Cost, Nicholas G. |
Report |
Jan 1, 2018 |
6838 |
| Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma. |
Hu, Brian; Daneshmand, Siamak |
Report |
Jan 1, 2018 |
3546 |
| Adrenal Metastasis of Hepatocellular Carcinoma in Patients following Liver Resection or Liver Transplantation: Experience from a Tertiary Referral Center. |
Teegen, Eva M.; Mogl, Martina T.; Pratschke, Johann; Rayes, Nada |
|
Jan 1, 2018 |
3761 |
| Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature. |
Dridi, Manel; Chraiet, Nesrine; Batti, Rim; Ayadi, Mouna; Mokrani, Amina; Meddeb, Khedija; Yahiaoui, |
Report |
Jan 1, 2018 |
2615 |
| Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution. |
Muratori, Francesco; Bettini, Leonardo; Frenos, Filippo; Mondanelli, Nicola; Greto, Daniela; Livi, L |
|
Jan 1, 2018 |
5212 |
| Health Related Quality of Life of Cancer Patients in Ethiopia. |
Abegaz, Tadesse Melaku; Ayele, Asnakew Achaw; Gebresillassie, Begashaw Melaku |
Clinical report |
Jan 1, 2018 |
5504 |
| The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma. |
Kim, Sung Han; Park, Eun Young; Joo, Jungnam; Chung, Jinsoo |
|
Jan 1, 2018 |
5958 |
| Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype. |
Wang, Xiaofang; Ma, Jinli; Mei, Xin; Yang, Zhaozhi; Yu, Xiaoli; Guo, Xiaomao; Zhang, Zhen; Shao, Zhi |
|
Jan 1, 2018 |
5410 |
| TFF1 and TFF3 mRNAs Are Higher in Blood from Breast Cancer Patients with Metastatic Disease than Those without. |
Elnagdy, Marwa H.; Farouk, Omar; Seleem, Amal K.; Nada, Hoda A. |
|
Jan 1, 2018 |
5057 |
| Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis. |
Zheng, Peng; Liang, Chunmin; Ren, Li; Zhu, Dexiang; Feng, Qingyang; Chang, Wenju; He, Guodong; Ye, L |
|
Jan 1, 2018 |
6488 |
| Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. |
Yu, Xinzhe; Gu, Jichun; Wu, Haoxuan; Fu, Deliang; Li, Ji; Jin, Chen |
Clinical report |
Jan 1, 2018 |
6016 |
| The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma. |
Ganju, Rohit Gunan; TenNapel, Mindi; Mahan, Nicholas; Zahra, Amir; Shen, Xinglei |
|
Jan 1, 2018 |
4410 |
| Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management. |
Lomax, Anna J.; Lim, Jennifer; Cheng, Robert; Sweeting, Arianne; Lowe, Patricia; McGill, Neil; Shack |
|
Jan 1, 2018 |
6277 |
| Local Treatment of Metastatic Prostate Cancer: What is the Evidence So Far? |
Almeida, Pedro Leonel; Pereira, Bruno Jorge |
Disease/Disorder overview |
Jan 1, 2018 |
4631 |
| A Complex Cardiac Mass Originating from Interatrial Septum in a Patient with History of Kidney Cancer: A Case Report and Literature Review. |
Faramarzi, Negar; Sohal, Sumit; Habibi, Roshanak; Akbar, Muhammad Sikander |
|
Jan 1, 2018 |
1547 |
| Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node. |
Shim, Jien; Rao, Jianyu; Yu, Run |
|
Jan 1, 2018 |
2119 |
| Development of Focal Nodular Hyperplasia after Cyclophosphamide-Based Chemotherapy in a Patient with Breast Cancer. |
Xue, Dan-Qing; Yang, Lan |
|
Jan 1, 2018 |
1906 |
| High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients. |
Schuster, Anne J.; Kager, Leo; Reichardt, Peter; Baumhoer, Daniel; Csoka, Monika; Hecker-Nolting, St |
Report |
Jan 1, 2018 |
6801 |
| Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma. |
Requile, Annelies; Clement, Paul M.; Bechter, Oliver E.; Dumez, Herlinde; Verbiest, Annelies; Sciot, |
|
Jan 1, 2018 |
4651 |
| SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy. |
Choy, Edwin; Ballman, Karla; Chen, James; Dickson, Mark A.; Chugh, Rashmi; George, Suzanne; Okuno, S |
Report |
Jan 1, 2018 |
5838 |
